New drug – better walking ability for MS patients!

Improvement Of Walking Ability In People With Multiple Sclerosis – Acorda Therapeutics Submits New Drug Application For Fampridine-SR (February 03.2009 – Medical News Today)

A new drug has been developed to improve the walking abilities in people with MS!! We all know that walking impairment is one of the most pervasive and alarming aspects of MS for us patients, our families and health care providers. So far, there were no medicines that would improve walking ability in people with MS. Thus, Fampridine-SR may represent an important new approach to treating and helping people with MS!

About Fampridine-SR

Fampridine-SR is a sustained-release tablet formulation of the investigational drug fampridine (4-aminopyridine or 4-AP). In laboratory studies, fampridine has been found to improve impulse conduction in nerve fibers in which the insulating layer, called myelin, has been damaged. As of June 2008, the Company completed two successful Phase 3 clinical trials to evaluate the safety and efficacy of Fampridine-SR in improving walking ability in people with MS.

2 Comments (+add yours?)

  1. hazelchimp
    Jul 02, 2012 @ 10:54:59

    Reblogged this on Web Presence Fampridine and commented:
    An amazing breakthrough…


  2. Trackback: Ampyra – improves walking speed for MS patients! « Multiple Sclerosis & Life

Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: